Canada Markets close in 27 mins

Emerald Health Therapeutics, Inc. (EMH.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1800+0.0050 (+2.86%)
As of 3:26PM EDT. Market open.
Currency in CAD

Valuation Measures

Market Cap (intraday) 536.03M
Enterprise Value 362.53M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.71
Price/Book (mrq)0.31
Enterprise Value/Revenue 32.97
Enterprise Value/EBITDA 6-1.47

Trading Information

Stock Price History

Beta (5Y Monthly) 0.90
52-Week Change 3-90.64%
S&P500 52-Week Change 3N/A
52 Week High 32.3000
52 Week Low 30.1200
50-Day Moving Average 30.1888
200-Day Moving Average 30.2050

Share Statistics

Avg Vol (3 month) 3935.39k
Avg Vol (10 day) 3610.78k
Shares Outstanding 5200.14M
Float 159.98M
% Held by Insiders 121.06%
% Held by Institutions 14.54%
Shares Short (Jul. 30, 2020) 4364.53k
Short Ratio (Jul. 30, 2020) 40.81
Short % of Float (Jul. 30, 2020) 4N/A
Short % of Shares Outstanding (Jul. 30, 2020) 40.18%
Shares Short (prior month Jun. 29, 2020) 4489.99k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Sep. 08, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Mar. 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-226.59%

Management Effectiveness

Return on Assets (ttm)-15.05%
Return on Equity (ttm)-80.96%

Income Statement

Revenue (ttm)21.08M
Revenue Per Share (ttm)0.14
Quarterly Revenue Growth (yoy)35.60%
Gross Profit (ttm)-10.79M
EBITDA -42.44M
Net Income Avi to Common (ttm)-112.43M
Diluted EPS (ttm)-0.7220
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)581k
Total Cash Per Share (mrq)0
Total Debt (mrq)29M
Total Debt/Equity (mrq)27.51
Current Ratio (mrq)0.59
Book Value Per Share (mrq)0.58

Cash Flow Statement

Operating Cash Flow (ttm)-19.06M
Levered Free Cash Flow (ttm)-52.27M